Millennium Management’s Indivior Pharmaceuticals INDV Stock Holding History

Millennium Management's INDV Position: Q2 2026 in Review

Millennium Management reduced its Indivior Pharmaceuticals (INDV) stake by 54% in Q2 2026, selling an estimated $90.6M and leaving 2,098,945 shares worth $86.1M. The position accounts for 0.03% of the portfolio, ranked #585.

Millennium Management first reported a position in INDV in Q1 2024 and has held it in 10 quarters since. The position peaked at $140M in Q1 2026. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

• Millennium Management held 2,098,945 shares of Indivior Pharmaceuticals worth $86.1M as of Q2 2026.
• Millennium Management sold 2,496,590 Indivior Pharmaceuticals shares in Q2 2026, an estimated $90.6M.
• Indivior Pharmaceuticals made up 0.03% of Millennium Management's portfolio in Q2 2026, its #585 holding.
• Millennium Management first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
• Millennium Management's Indivior Pharmaceuticals position peaked at $140M in Q1 2026.
• 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.